Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,154,613
-
Share change
-
+3,154,613
-
Total reported value
-
$45,797,000
-
Price per share
-
$14.53
-
Number of holders
-
40
-
Value change
-
+$45,797,000
-
Number of buys
-
40
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q1 2021
As of 31 Mar 2021,
Sensei Biotherapeutics, Inc. - COM (SNSE) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,154,613 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., VANGUARD GROUP INC, Falcon Edge Capital, LP, JPMORGAN CHASE & CO, MOORE CAPITAL MANAGEMENT, LP, GEODE CAPITAL MANAGEMENT, LLC, Tudor Investment Corp Et Al, and Duquesne Family Office LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.